Parallel Bio a pioneering biotech company focused on leveraging the immune system to combat diseases has introduced its latest innovation the Clinical Trial in a Dish This revolutionary
Voyager Therapeutics Inc a biotech company focused on neurogenetic medicines announced the dosing of the first participants in its Phase a single ascending dose trial of VYTAU
Ocugen Inc a biotechnology company focused on developing novel gene and cell therapies as well as vaccines has announced the completion of dosing in the second cohort of its Phase GARDian clinical trial
Arexvy the worlds first respiratory syncytial virus vaccine has recently gained approval from the Health Sciences Authority of Singapore for immunizing individuals aged years and above against lower respiratory tract disease caused by RSV This groundbreaking achievement underscores GSKs commitment
Ractigen Therapeutics a leading clinicalstage pharmaceutical company dedicated to developing innovative therapies has announced a significant achievement the approval of its Investigational New Drug
Zai Lab Limited has announced that the Center for Drug Evaluation of the China National Medical Products Administration has accepted the supplemental Biologics License Application
Glenmark Pharmaceuticals Ltd has received final approval by the United States Food Drug Administration for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution Glenmarks Brimonidine Tartrate
Oragenics Inc a pioneering pharmaceutical company specializing in intranasal treatments for neurological disorders today announced an update on the company and its drug development program
Axonics Inc today announced that it has received regulatory approval from the Therapeutic Goods Administration for marketing the Axonics F rechargefree sacral neuromodulation system in Australia to treat adults with overactive bladder Approval of the Axonics rechargefree system
Reviva Pharmaceuticals Holdings Inc a latestage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system
EVQ Bio a whollyowned subsidiary of EVQ Nano today announced the successful completion of a PreInvestigational New Drug meeting with the US Food and Drug Administration
Nitrosamine Advance Workshop conducted on May th and th at Radisson Blu Mumbai International Airport has emerged as a watershed moment in the pharma industry boosting collaboration and innovation in the detection of the Nitrosamine landscape
Czech, Republic
Prague, Czech Republic
Berlin, Germany
Boston, MA, USA
Pennsylvania, USA
Boston, MA, USA
BASEL, SWITZERLAND
Sydney‚ Australia
Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be) University
Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be) University
Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be) University; Department of Entomology, University of California; UC Davis Comprehensive Cancer Center, University of California. Electronic address: dileep.0@gmail.com
Assistant Professor,Department of Applied Sciences, Indian Institute of Information Technology
Research Fellow, Department of Applied Sciences, Indian Institute of Information Technology
Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER)
Doctoral Research Scholar, Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER)
Protein Biochemist
Assistant Professor , Department of Pharmaceutics at L. M. College of Pharmacy
Research Student, Pursuing M. Pharmacy, Pharmaceutics, L. M. College of Pharmacy
Tendering Manager Asia-Pacific
Powder Systems Limited PSL has been exporting its technology to the AsiaPacific market since and a growing number of turnkey installations are to be commissioned in this region in the future To support the demand PSL has committed to further investment in AsiaPacific APAC by opening an engineering and sales office in Singapore This addition to PSL APAC will reinforce the fast growing activities c...Patienttailored treatment can be a challenge with conventional
AbstractMounting evidence demonstrates that CYPB plays a much larger role in human drug metabolism than was previously believed The discovery of multiple important substrates of CYPB as well as polymorphic differences has sparked increasing interest in the genetic and xenobiotic factors contributing to the expression and function of the enzyme The expression
AbstractObjectivesNational Institute for Health and Care Excellence guidelines recommend immediate antibiotic treatment of respiratory tract infections in atrisk individuals with comorbidities Observational evidence suggests that influenza particularly predisposes children to bacterial comp
Axsome Therapeutics Inc discovered AXS novel therapy for the treatment of cataplexy in patients with narcolepsy AXS is an oral highly selective and potent norepinephrine reuptake inhibitor AXS developed for cataplexy highlights its potential and provides meaningful benefit and substantial improvement for patients over currently available treatment
Sarika Khasnis Research Analyst Beroe IncAbstractThe trade group Pharma for large pharmaceuticals has announced that industry has more than biologics under development having different therapeutic area focus The biologics market is estimated to be approximately billion by with a gr
Approximately million people worldwide are living with a rare disease and about half of those affected by rare diseases are children
Although less well known than other drug development phases human factors engineering HFE is critical to meeting regulatory expectations for drugdevic...
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Many advanced largescale AI initiatives still need to be proved successful in Pharma
Singapore has had a multidecade longterm vision for building a worldclass biomedical cluster